Introduction {#S0001}
============

Chronic kidney disease (CKD) is progressive, irreversible damage to the kidneys, which leads to inability of the kidneys to perform homeostatic, synthetic and excretory functions. Estimated epidemiological prevalence of CKD in global and sub-Saharan Africa was reported to be 15% and 10% respectively.[@CIT0001]--[@CIT0007] The evident reasons for escalating burden of kidney failure in Africa were due to growing urbanization, environmental pollutant exposure, high burden of infectious diseases and increasing rate of noncommunicable diseases such as diabetes and hypertension.[@CIT0005]--[@CIT0007]

Common etiologies of CKD in Africa were hypertension, chronic glomerulonephritis and diabetes. Ten percent of HIV-positive patients were documented to have renal dysfunction. Complications of CKD included anemia, metabolic bone disease, metabolic acidosis, fluid and electrolyte imbalance and uremia, which imposed considerable burden on health care resources.[@CIT0005]--[@CIT0007],[@CIT0011]--[@CIT0014]

Anemia is a common and significant complication in CKD patients. Study-based estimated prevalence of anemia was 15% in US CKD patients, 45--55% in Asian CKD patients, and 50--90% in African CKD patients.[@CIT0003],[@CIT0004],[@CIT0011]--[@CIT0013]

The etiopathogenesis of anemia in CKD is multifactorial and includes erythropoietin deficiency from reduced renal mass, uremic environment-induced inhibitors of erythropoiesis, shortened red cell survival, and disordered iron homeostasis.[@CIT0008],[@CIT0009]

Anemia in CKD patients is significantly associated with worsening CKD, and development of heart failure and stroke. It contributes to impaired physical activity, neurocognitive dysfunction and poor quality of life.[@CIT0009]--[@CIT0013],[@CIT0015],[@CIT0016],[@CIT0022]--[@CIT0024]

Documented predictors of anemia in CKD include, but are not restricted to, female gender, advanced stage of CKD, diabetic nephropathy as etiology, nonsmoking status, nonobese body habitus, low serum albumin, abnormal bone minerals level (high phosphorus and low calcium levels), abnormal iron markers (transferrin saturation \<20%), and low leukocyte count.[@CIT0004],[@CIT0013],[@CIT0017]

However, prevalence of anemia of CKD in Northwest Ethiopia has not been fully investigated. Therefore, we aimed to disclose prevalence of anemia and its associated factors among CKD patients in the setting.

Methods {#S0002}
=======

Study Settings And Design {#S0002-S2001}
-------------------------

A hospital-based cross sectional study was conducted from May 1, 2018 to September 30, 2018 at the University of Gondar hospital. The hospital is located in Northwest Ethiopia, which is 750 km away from the capital, Addis Ababa. The hospital has a catchment population of five million people.

Study Subjects And Variables {#S0002-S2002}
----------------------------

Source population was all CKD patients visiting University of Gondar hospital. Patients 18 years and above with an established diagnosis of CKD as per kidney disease/improving global outcomes (KDIGO) criteria regardless of its primary cause were considered as study population. Those study subjects who provided informed consent were included in the study. Patients with known cause of anemia other than kidney disease, pregnant women, and those unwilling to participate were excluded.

Sample Size And Sampling Procedure {#S0002-S2003}
----------------------------------

The sample size was calculated using Fisher's formula[@CIT0018] at a prevalence of 80% with a confidence interval of 95% and degree of precision of 5%. Consecutive sampling was used to recruit 251 study subjects.

Data Collection {#S0002-S2004}
---------------

Data were collected through an investigator administered pretested questionnaire. Patients were interviewed to obtain demographic data, and the patients' medical records were reviewed to obtain information on relevant medical history and laboratory parameters. The determination of the primary cause of kidney disease was based on clinical history, physical examination, and laboratory investigations including complete blood count, urinalysis, blood chemistry, ultrasound and HIV serology.

Blood and urine samples were collected for laboratory tests. Complete blood counts were obtained after processing the blood sample using AR-6300 (ARI Medical Equipment Co. Ltd, China) hematology analyzer. Serum glucose and creatinine were determined by enzymatic glucose oxidase and kinetic alkaline picrate method respectively using Mindray BS-480 (Shenzhen Mindray Bio-Medical Electronics Co., Ltd, China) clinical chemistry analyzer. Urine albumin was measured semiquantitatively by dip stick urinalysis (COMBINA 11S, Human) using fresh, midstream urine samples.

The hemoglobin level was used to define anemia according to WHO criteria.[@CIT0019] The serum creatinine was used to estimate GFR using chronic kidney disease epidemiology collaboration (CKD-EPI) equation.[@CIT0020]

Dependent variable: anemia was the dependent variable, as defined by WHO criteria.

Independent variables: sociodemographic factors including age, sex, place of residence, educational status and marital status; behavioral factors including smoking and alcohol drinking; and clinical parameters such as cause, duration and stage of CKD, presence of comorbidity, dialysis status, body mass index (BMI), blood pressure level, presence/absence of albuminuria and treatment status for anemia.

Data Analysis {#S0002-S2005}
-------------

Data was entered into EPI Info version 4.4.1 and transported to SPSS version 20 for analysis. Descriptive statistics, such as median and IQRs were used to compute continuous variables, and counts with percentage for categorical variables. Both bivariate and multivariate logistic regression analyses were used to identify independently associated factors of anemia in CKD patients. Those variables with a *P*-value \<0.2 in the bivariate analysis were exported to multivariate analysis to control the possible effect of confounders. Adjusted odds ratio (AOR) with 95%CI and *P*-value \<0.05 were used to select variables associated with anemia in CKD patients.

Definition Of Terms {#S0002-S2006}
-------------------

Chronic kidney disease (CKD) was defined as abnormalities of kidney structure or function present for more than three months, with implications for health. CKD is classified based on cause and GFR category (G1--G5). GFR was determined by using CKD-EPI equation for eGFR, stage 1, albuminuria with eGFR \>90 mL/min/1.73m^2^; stage 2, albuminuria with eGFR 60--89 mL/min/1.73m^2^; stage 3a, eGFR 45--59ml/min/1.73m^2^; stage 3b, eGFR 30--44 mL/min/1.73m^2^; stage 4, eGFR 15--29 mL/min/1.73m^2^; and stage 5, eGFR\<15 mL/min/1.73m^2^.

Anemia was defined as hemoglobin level \<12g/dL in females and \<13g/dL in males in patients aged 18 years of age and above. Severity of anemia was classified as mild (11--11.9 g/dL (females), 11--12.9 g/dL (males)), moderate (8--11 g/dL), and severe (\<8 g/dL).

Albuminuria was defined as presence of albumin in the urine (from trace to 4+). Massive proteinuria is defined as albumin in urine of 2+ in two of three determinations over three months.

Hypertension was defined as the presence of persistently elevated systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg in patients aged 18 years of age and above, history of hypertension, or the use of antihypertensive drug(s).

Hypertensive kidney disease was defined as presence of documented history of hypertension predated kidney disease (reduced eGFR).

Diabetes was defined as fasting serum glucose ≥126 mg/dL, history of diabetes, or use medications for diabetes.

Diabetic nephropathy (DN) was defined as long-standing known diabetes, and urinalysis evidence of significant proteinuria.

Chronic glomerulonephritis was defined as presence of proteinuria, hematuria, and/or ultrasound-proven reduced kidney size (≤8 cm) or loss of cortico-medullary differentiation.

Ethical Considerations {#S0002-S2007}
----------------------

Ethical clearance was obtained from the Research Ethical Review Board of College of Medicine and Health Sciences, University of Gondar. Formal letter of permission was obtained from University of Gondar hospital administrative body. Written informed consent was obtained from participants, and confidentiality of information obtained was maintained by coding and restricting access to the questionnaire. During the data collection process, those patients who were found to have anemia were taken care of as per the recommendations of CKD guidelines, and advice on preventive measures was given to all participants.

Result {#S0003}
======

Sociodemographic Characteristics Of Study Participants {#S0003-S2001}
------------------------------------------------------

Among a total of 251 CKD patients, 161 (64.1%) were males and 90 (35.9%) were females. The median age of study subjects was 60 years (IQR=44--69). The majority of patients (61%) were aged from 45 to 75 years. Most of them were nonsmokers (95%), nonalcoholic (76%), married (77%), and Orthodox Christian by religion (84%). The majority 142 (57%) were urban dwellers and 118 (47%) joined formal education ([Table 1](#T0001){ref-type="table"}).Table 1Sociodemographic Characteristics Of CKD Patients (N=251)VariablesFrequency (%)Anemia*P*-valuePresentAbsentSex Male161 (64.1)102590.599 Female90 (35.9)6030Age (years) 19--3030 (12.0)2460.003 31--4540 (15.9)337 46--6078 (31.1)4038 61--7575 (29.9)5025 76--8528 (11.1)1513Residence Urban142 (56.6)7666\<0.001 Rural109 (43.4)8623Occupation Civil servant43 (17.1)2122\<0.001 Merchant37 (14.7)1819 Farmer61 (24.3)529 Housewife60 (23.9)4317 Self-employed13 (5.2)94 Daily laborer11 (4.4)92 Student5 (2.0)32 Others^a^21 (8.4)714Religion Orthodox Christian210 (83.7)143670.018 Protestant Christian4 (1.6)22 Muslim37 (14.7)1720Marital status Single22 (8.8)1570.767 Married193 (76.9)12469 Divorced21 (8.3)129 Widowed15 (6.0)114Educational status Unable to read and write101 (40.2)78230.007 Able to read and write32 (12.7)2012 Primary education41 (16.3)2516 Secondary education37 (14.7)2017 College and above40 (15.9)1921[^1]

Clinical and Laboratory Profile Of CKD Patients {#S0003-S2002}
-----------------------------------------------

Hypertension accounted for 45% as a cause of CKD, followed by chronic glomerulonephritis (24%) and diabetes (20%). HIV/AIDS was ascertained as etiology of CKD in 2% of cases ([Table 2](#T0002){ref-type="table"}). Majority of the patients were in KDIGO stage 3 (49%), followed by KDIGO stage 5 (26%) and stage 4 (21%) ([Figure 1](#F0001){ref-type="fig"}). Two-thirds of patients 180 (71.7%) were positive for albuminuria using urinalysis dipstick. One hundred four (53.3%) had massive proteinuria (≥2+ albuminuria). One-fifth 51 (20.3%) had ultrasound-proven bilateral shrunken kidneys (≤8 cm) ([Table 3](#T0003){ref-type="table"}).Table 2Clinical Characteristics Of CKD Patients (N=251)VariablesFrequency (%)Anemia*P*-valuePresentAbsentTreatment status for anemia Yes42 (16.7)420\<0.001 No209 (83.3)12089Type of treatment for treated cases Blood transfusion (BT)19190? Hematinics only14140 BT and hematinics330 Hematinics and ESA550 BT, hematinics, and ESA110Smoking Yes13 (5.2)760.408 No238 (94.8)15583Alcohol drinking Yes61 (24.3)39220.909 No190 (75.7)12367Presence of comorbidity Yes88 (35.1)58600.014 No163 (64.9)10459Taking other medications^a^ Yes212 (84.1)132790.132 No40 (15.9)3010Family history of kidney disease Yes10 (4.0)910.085 No241 (96.0)15388Underlying cause of CKD Chronic GN60 (23.9)546\<0.001 Hypertension115 (45.4)6648 Diabetes51 (20.9)2328 Others26 (9.8)206Hemodialysis history Yes32 (12.7)2660.034 No219 (87.3)13683SBP category (mmHg) ≥16038 (15.1)22160.151 150--15968 (27.1)4127 120--13985 (33.9)5332 90--11960 (23.9)4614DBP category (mmHg) ≥10021 (8.4)1650.033 90--9952 (20.7)3121 80--8970 (27.9)3733 60--79108 (43.0)7830BMI (kg/m^2^) \<18.543 (17.1)358\<0.001 18.5--24.9160 (63.7)10951 25--29.931 (12.4)1417 ≥3017 (6.8)413[^2] Table 3Laboratory And Imaging Profile Of CKD Patients (N=251)VariablesFrequency (%)Anemia*P*-valuePresentAbsentAlbuminuria on urinalysis dipstick Present180 (71.7)120600.264 Absent71 (28.3)4229Degree of albuminuria Negative71 (28.3)42290.025 1+46 (18.3)2323 2+101 (40.2)7526 3+33 (13.2)2211eGFR (mL/min/1.73m^2^) Early stage (stage 1/2)10 (4.0)28\<0.001 Stage 3A (45--59.99)67 (26.7)3037 Stage 3B (30--44.99)56 (22.3)2630 Stage 4 (15--29.99)53 (21.1)4310 Stage 5 (≤14.99)65 (25.9)614Renal ultrasound findings Normal sized kidneys123 (49.0)71520.264 Shrunken kidneys51 (20.3)3516 Large kidneys4 (1.6)31 Congenital anomalies9 (3.6)54 Obstructive15 (6.0)114 Others49 (19.5)3712HIV status Reactive12 (4.8)1020.002 Nonreactive99 (39.4)7524 Unknown140 (55.8)7763 Figure 1Stages of CKD by eGFR using CKD-EPI equation.

Prevalence Of Anemia Among CKD Patients {#S0003-S2003}
---------------------------------------

The overall prevalence of anemia in this study was 64.5% (58.6 to 70.5%). Anemia was significantly prevalent in glomerular disease among other underlying causes of CKD (*P*-value \<0.001) ([Figure 2](#F0002){ref-type="fig"}). The prevalence of anemia increased with worsening kidney function: stage 1 and 2, 3A, 3B, 4 and 5 CKD were 20%, 44.8%, 46.4%, 81.1%, 93.8% respectively ([Figure 3](#F0003){ref-type="fig"}). Severe anemia (Hgb \<8g/dL) was documented in 49/251 (19.5%) of CKD patients. One quarter (42/162) of patients received therapy among those who had documented anemia. Options of therapy among treated cases were packed blood transfusions 23/42 (55%), hematinics 23/42 (55%), and erythropoiesis stimulating agent (ESA) 6/42 (14.3%) ([Table 2](#T0002){ref-type="table"}).Figure 2The prevalence of anemia across the underlying causes of CKD.Figure 3Prevalence of anemia across stages of CKD.

Factors Associated With Anemia Among CKD Patients {#S0003-S2004}
-------------------------------------------------

Multivariate logistic regression analysis was used to identify independently associated factors of anemia among CKD patients. Accordingly, rural residence (AOR=2.75, 95%CI: 1.34--5.65, *P*=0.006), BMI \<18.5 kg/m^2^ (AOR=6.78, 95%CI: 1.32--34.73, *P*=0.022) and BMI of 18.5--24.9 kg/m^2^ (AOR=5.04, 95%CI: 1.26--20.10, *P*=0.022) and, having hemodialysis history (AOR=3.59, 95%CI: 1.24--10.38, *P*=0.018) were found to be associated with anemia among CKD patients. Those with diastolic blood pressure (DBP) between 80 and 89 mmHg (AOR=0.37, 95%CI: 0.16--0.92, *P*=0.025) were at lower risk for anemia of CKD ([Table 4](#T0004){ref-type="table"}).Table 4Bivariate And Multivariate Logistic Regression Analysis Of Factors Associated With Anemia Among CKD Patients At University Of Gondar Hospital, Northwest Ethiopia, May 1, To September 30, 2018 (N=251)VariableAnemiaCOR (95%CI)AOR (95%CI)*P*--valuePresentAbsent**Sex** Male102591 Female60301.16 (0.67--1.99)**Age (years)** 19--3024611 31--453371.18 (0.35--3.96)1.30 (0.34--5.07) 46--6040380.26 (0.01--0.71)0.53 (0.16--1.71) 61--7550250.50 (0.18--1.38)1.00 (0.29--3.42) 76--8515130.29 (0.09--0.92)0.69 (0.16--2.94)**Residence** Urban766611 Rural86233.25 (1.84--5.72)2.75 (1.34--5.65)0.006**Educational status** Unable to read &write78233.75 (1.73--8.14)1.65 (0.58--4.64) Able to read and write20121.84 (0.71--4.75)1.46 (0.46--4.66) Primary education (1--8)25161.73 (0.72--4.17)1.14 (0.38--3.37) Secondary education (9--10)1262.21 (0.69--7.05)1.31 (0.33--5.17) Preparatory (11--12)8110.80 (0.27--2.42)0.71 (0.17--2.88) College and above192111**Marital status** Married124691 Single1571.19 (0.46--3.07) Divorced1290.74 (0.30--1.85) Widowed1141.53 (0.47--4.99)**Alcohol drinking** Yes39220.97 (0.53--1.76) No123671**Presence of comorbidity** Yes58301.01 (0.64--1.89) No104591**Taking other medications** Yes132790.56 (0.26--1.20)0.79 (0.30--2.08) No301011**SBP category (mmHg)** 90--119461411 120--13953320.50 (0.24--1.06)1.38 (0.52--3.65) 140--15941270.46 (0.21--1.00)1.03 (0.34--3.14) 160+22160.42 (0.17--1.00)0.96 (0.25--3.59)**DBP category(mmHg)** 60--79783011 80--8937330.43 (0.23--0.81)0.38 (0.16--0.92)0.025 90--9931210.57 (0.28--1.14)0.62 (0.23--1.71) 100+1651.23 (0.41--3.67)1.69 (0.35--8.09)**Hemodialysis status** Yes2662.24 (0.93--5.39)3.59 (1.24--10.38)0.018 No1368311**BMI (kg/m^2^)** 10--18.4935814.22 (3.66--55.32)6.78 (1.32--34.73)0.022 18.5--24.9109516.95 (2.16--22.36)5.04 (1.26--20.10)0.022 25--29.914172.68 (0.71--10.07)3.14 (0.63--15.77) 30--5041311**Proteinuria on urinalysis dipstick** Absent42291 Present120601.38 (0.78--2.43)**Degree of proteinuria** None422911 1+23230.69 (0.33--1.46)0.58 (0.23--1.47) 2+75261.99 (1.04--3.82)1.82 (0.83--4.00) 3+22111.38 (0.58--3.28)1.66 (0.57--4.80)**WBC count**Median=6 (IQR=5--8)1.09 (0.98--1.22)1.07 (0.94--1.21)**Neutrophil (%)**Median=70 (IQR=61--76)1.01 (0.99--1.03)1.02 (0.97--1.07)**Lymphocyte (%)**Median=23 (IQR=14.7--30)0.98 (0.96--0.99)0.99 (0.95--1.05)**Platelet count**Mean=247.91 (SD=102.7)0.99 (0.99--1.00)[^3]

Discussion {#S0004}
==========

The overall prevalence of anemia among CKD stages 1--5 was 64.5%, with in the range in African studies report (51--87%).[@CIT0008],[@CIT0011]--[@CIT0013] Recent NHANES report in the United States revealed the prevalence of anemia was twice (15.4%) in CKD patients compared to the nonCKD population (7.5%).[@CIT0002],[@CIT0003]

The study demonstrated prevalence of anemia increased with stage of CKD. A similar finding was reported from NHANES survey in the United States with prevalence of anemia from 8.4% at stage 1 to 53.4% at stage 5. Comparable trend was also observed from recent Korean cohort with prevalence of 10% at stage 1 to 96.5% at stage 5.[@CIT0002],[@CIT0004]

The main etiologies of CKD were hypertension, chronic glomerulonephritis and diabetes, congruent with studies from low and middle-income countries.[@CIT0005],[@CIT0007],[@CIT0009]--[@CIT0014] Chronic glomerulonephritis remained an important cause of CKD, possibly related to high prevalence of viral, bacterial, protozoan and helminthic infections/infestations in sub-Saharan Africa.[@CIT0009]--[@CIT0013]

As in other developing countries, most patients (96%) in this study presented in advanced stage of CKD (stage 3--5), unlike the situation in developed countries. Presumed reasons for patients' late presentation for renal medical care might be due to low detection and treatment rate of CKD risk factors such as hypertension and diabetes, lack of regular CKD screening program and insufficient follow-up care, and preference to use alternative treatment.[@CIT0004],[@CIT0006],[@CIT0007],[@CIT0010],[@CIT0012],[@CIT0013]

This study demonstrated anemia was significantly prevalent in CKD of chronic glomerulonephritis compared to other underlying causes of CKD (*P*-value \<0.001). Studies from the Western world documented diabetic nephropathy were strongly correlated with anemia of CKD among other underlying causes. Putative reasons for high prevalence of anemia in diabetic nephropathy might be hyperglycemia-induced renal interstitial fibrosis, decrease in hypoxia-inducible transcription factor, and increase in inflammatory cytokines.[@CIT0004],[@CIT0012],[@CIT0017]

This study showed that anemia was significantly prevalent in rural residents. The odds of being anemic were threefold higher in rural residents (AOR=2.75, 95%CI: 1.34--5.65, *P*=0.006) as compared to urban dwellers. Rural resident patients might visit health facility late due to lack of access to or remote from health care service. Concomitant presence of nutritional deficiencies, gastrointestinal blood loss or helminthic infestations might contribute to anemia in rural residents.[@CIT0010],[@CIT0013]

Patients with nonobese body habitus had five to sevenfold increased risk for anemia compared to patients with obese body habitus. A cohort study in Korea showed lower BMI was associated with elevated risk of anemia, while lower odds for anemia was reported for higher BMI. Malnutrition defined by protein-energy wasting is indicator of advanced renal disease.[@CIT0004]

Patients with hemodialysis history had fourfold higher odds for anemia (AOR=3.59, 95%CI: 1.24--10.38, *P*=0.018) compared to patients without hemodialysis history. Various studies revealed hemodialysis requiring patients were those with advanced renal disease, in which presence and severity of anemia was prevalent. Intractable anemic state in later stages of CKD is mainly due to inflammation, protein-energy wasting and bone marrow fibrosis.[@CIT0009],[@CIT0011],[@CIT0012]

There was a 63% less likely chance of developing anemia among patients with DBP (80--89 mmHg) (AOR=0.37, 95%CI: 0.16--0.92, *P*=0.025). Normal or controlled blood pressure in CKD patients might indicate early stage renal disease or attenuated renal disease progression respectively.[@CIT0021]

Literatures revealed anemia of CKD caused maladaptive cardiovascular mechanisms leading to left ventricular hypertrophy, heart failure, and myocardial ischemia and infarction. Anemia with CKD was also associated with a substantial higher risk of stroke. As well, it increased risk of cardiovascular related morbidity and mortality.[@CIT0009],[@CIT0015],[@CIT0016],[@CIT0022]--[@CIT0025]

Suboptimal treatment of anemia with ESA and hematinics were noticed in this study, possibly explained by unavailability or high cost of drugs. Clinical studies have shown that correction of anemia using ESA and hematinics improved quality of life, physical activity and cardiac function, and might decrease kidney disease progression and morbidity.[@CIT0011]--[@CIT0013],[@CIT0016],[@CIT0020],[@CIT0025]

Limitation Of The Study {#S0005}
=======================

Data were cross-sectional, not longitudinal, preventing assessment of whether identified associated factors caused or resulted from CKD. Type and cause of anemia in CKD patients were not determined due to logistic reasons. Albuminuria was evaluated using a semiquantitative urine dipstick test due to unavailability of quantitative albuminuria test.

Conclusion {#S0006}
==========

Hypertension (45%), chronic glomerulonephritis (24%) and diabetes (20%) were common causes of CKD. Anemia was prevalent across stages of chronic kidney disease, and worsened with progressive decline in kidney function. Rural residence, nonobese body habitus and having hemodialysis history were independently associated with anemia in CKD patients.

Recommendation {#S0006-S2001}
--------------

The authors recommend longitudinal studies to determine actual predictors of anemia in CKD patients. Periodic screening and intervention programs for anemia of CKD should be practiced to change the existing situation in the setting.
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